Shareholder Wei Xuening of Changchun Bcht Biotechnology Co., Ltd. (688276.SH) has reduced his holding by a total of 301,800 shares in the company.
Baike Biological (688276.SH) issued a statement on January 15, 2025, stating that the company has received a letter from shareholder Wei Xueling...
Changchun Bcht Biotechnology (688276.SH) announced that on January 15, 2025, the company received a notice from shareholder Mr. Wei Xuening regarding the implementation results of the reduction plan. The reduction results are as follows: Mr. Wei Xuening reduced his holdings in the company by a total of 301,800 shares through centralized bidding trading, accounting for 0.0730% of the total share capital of the company. As of the disclosure date of this announcement, the time period for this reduction plan has been completed.
Related Articles

Guosen: Residents' deposits continue to flow towards non-bank financial institutions, with insurance being an important direction for attracting funds.

New Stock Preview | Slender West Lake Tourism: From selling boat tickets to selling experiences, "cash cow" also has hidden worries.

China Securities Co., Ltd.: Continued high prosperity in the global optical communication industry, five years of growth expected.
Guosen: Residents' deposits continue to flow towards non-bank financial institutions, with insurance being an important direction for attracting funds.

New Stock Preview | Slender West Lake Tourism: From selling boat tickets to selling experiences, "cash cow" also has hidden worries.

China Securities Co., Ltd.: Continued high prosperity in the global optical communication industry, five years of growth expected.

RECOMMEND

Hong Kong Hard‑Tech Companies Enhance Canton Fair Presence As Veterans And Newcomers Expand International Networks
17/04/2026

Thousand‑Fold Oversubscription In Hong Kong IPOs Signals Multiple Market Shifts
17/04/2026

Rising Compute Costs Drive Industry Price Increases As Institutions Expect Internet Firms To Outperform In Q1
17/04/2026


